Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia

References

• Sanderson PA, Critchley HO, Williams AR, et al. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017;23(2):232–254. doi: 10.1093/humupd/dmw042.
   PubMed Web of Science ®Google Scholar
• Emons G, Beckmann MW, Schmidt D, et al. New WHO classification of endometrial hyperplasias. Geburtshilfe Frauenheilkd. 2015;75(2):135–136. doi: 10.1055/s-0034-1396256.
   PubMed Web of Science ®Google Scholar
• Gunderson CC, Fader AN, Carson KA, et al. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012;125(2):477–482. doi: 10.1016/j.ygyno.2012.01.003.
   PubMed Web of Science ®Google Scholar
• Catena U, Della Corte L, Raffone A, et al. Fertility-sparing treatment for endometrial cancer and atypical endometrial hyperplasia in patients with lynch syndrome: molecular diagnosis after immunohistochemistry of MMR proteins. Front Med (Lausanne). 2022;9:948509. doi: 10.3389/fmed.2022.948509.
   PubMed Web of Science ®Google Scholar
• Lacey JV, Jr, Sherman ME, Rush BB, et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol. 2010;28(5):788–792. doi: 10.1200/JCO.2009.24.1315.
   PubMed Web of Science ®Google Scholar
• Auclair MH, Yong PJ, Salvador S, et al. Guideline no. 390-classification and management of endometrial hyperplasia. J Obstet Gynaecol Can. 2019;41(12):1789–1800. doi: 10.1016/j.jogc.2019.03.025.
   PubMed Web of Science ®Google Scholar
• Gallos ID, Shehmar M, Thangaratinam S, et al. Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010;203(6):547.e1–547.10. doi: 10.1016/j.ajog.2010.07.037.
   PubMed Web of Science ®Google Scholar
• Hui LS, Chin SHM, Goh C, et al. Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy. Obstet Gynecol Sci. 2021;64(3):300–308. doi: 10.5468/ogs.20294.
   PubMedGoogle Scholar
• Rotenberg O, Fridman D, Doulaveris G, et al. Long-term outcome of postmenopausal women with non-atypical endometrial hyperplasia on endometrial sampling. Ultrasound Obstet Gynecol. 2020;55(4):546–551. doi: 10.1002/uog.20421.
   PubMed Web of Science ®Google Scholar
• Opolskiene G, Sladkevicius P, Valentin L. Prediction of endometrial malignancy in women with postmenopausal bleeding and sonographic endometrial thickness ≥ 4.5 mm. Ultrasound Obstet Gynecol. 2011;37(2):232–240. doi: 10.1002/uog.8871.
   PubMed Web of Science ®Google Scholar
• Göl K, Saraçoğlu F, Ekici A, et al. Endometrial patterns and endocrinologic characteristics of asymptomatic menopausal women. Gynecol Endocrinol. 2001;15(1):63–67. doi: 10.1080/gye.15.1.63.67.
   PubMed Web of Science ®Google Scholar
• Zeleniuch-Jacquotte A, Akhmedkhanov A, Kato I, et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer. 2001;84(7):975–981. doi: 10.1054/bjoc.2001.1704.
   PubMed Web of Science ®Google Scholar
• Lukanova A, Lundin E, Micheli A, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer. 2004;108(3):425–432. doi: 10.1002/ijc.11529.
   PubMed Web of Science ®Google Scholar
• Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987;45(1 Suppl):277–282. doi: 10.1093/ajcn/45.1.277.
   PubMed Web of Science ®Google Scholar
• Li J, Chu R, Chen Z, et al. Progress in the management of ovarian granulosa cell tumor: a review. Acta Obstet Gynecol Scand. 2021;100(10):1771–1778. doi: 10.1111/aogs.14189.
   PubMed Web of Science ®Google Scholar
• Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21(6):1180–1189. doi: 10.1200/JCO.2003.10.019.
   PubMed Web of Science ®Google Scholar
• Zanagnolo V, Pasinetti B, Sartori E. Clinical review of 63 cases of sex cord stromal tumors. Eur J Gynaecol Oncol. 2004;25(4):431–438.
   PubMed Web of Science ®Google Scholar
• Committee Opinion No. 601: tamoxifen and uterine cancer. Obstet Gynecol. 2014;123(6):1394–1397.
   PubMedGoogle Scholar
• Strom BL, Schinnar R, Weber AL, et al. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol. 2006;164(8):775–786. doi: 10.1093/aje/kwj316.
   PubMed Web of Science ®Google Scholar
• Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the million women study. Lancet. 2005;365(9470):1543–1551. doi: 10.1016/S0140-6736(05)66455-0.
   PubMed Web of Science ®Google Scholar
• Furness S, Roberts H, Marjoribanks J, et al. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2009;(2):Cd000402.
   Google Scholar
• Kim MJ, Kim JJ, Kim SM. Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women. Obstet Gynecol Sci. 2016;59(3):192–200. doi: 10.5468/ogs.2016.59.3.192.
   PubMedGoogle Scholar
• Spadoto-Dias D, Bueloni-Dias FN, Elias LV, et al. The value of hysteroscopic biopsy in the diagnosis of endometrial polyps. Womens Health (Lond). 2016;12(4):412–419. doi: 10.1177/1745505716653695.
   PubMedGoogle Scholar
• Chawla I, Tripathi S, Vohra P, et al. To evaluate the accuracy of Saline Infusion Sonohysterography (SIS) for evaluation of uterine cavity abnormalities in patients with abnormal uterine bleeding. J Obstet Gynaecol India. 2014;64(3):197–201. doi: 10.1007/s13224-013-0501-4.
   PubMedGoogle Scholar
• Bakir B, Sanli S, Bakir VL, et al. Role of diffusion weighted MRI in the differential diagnosis of endometrial cancer, polyp, hyperplasia, and physiological thickening. Clin Imaging. 2017;41:86–94. doi: 10.1016/j.clinimag.2016.10.016.
   PubMed Web of Science ®Google Scholar
• Ofinran O, Balega J. The value of magnetic resonance imaging in investigating complex atypical hyperplasia of the endometrium. Minerva Ginecol. 2016;68(4):400–404.
   PubMedGoogle Scholar
• Bogani G, Gostout BS, Dowdy SC, et al. Clinical utility of preoperative computed tomography in patients with endometrial cancer. Int J Gynecol Cancer. 2017;27(8):1685–1693. doi: 10.1097/IGC.0000000000001076.
   PubMed Web of Science ®Google Scholar
• Gupta P, Gupta N, Dey P. Morphometric analysis of endometrial cells in liquid-based cervical cytology samples. Cytopathology. 2017;28(2):140–148. doi: 10.1111/cyt.12364.
   PubMed Web of Science ®Google Scholar
• Yang X, Ma K, Chen R, et al. Liquid-based endometrial cytology associated with curettage in the investigation of endometrial carcinoma in a population of 1987 women. Arch Gynecol Obstet. 2017;296(1):99–105. doi: 10.1007/s00404-017-4400-2.
   PubMed Web of Science ®Google Scholar
• van Hanegem N, Prins MM, Bongers MY, et al. The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2016;197:147–155. doi: 10.1016/j.ejogrb.2015.12.008.
   PubMed Web of Science ®Google Scholar
• Yao Y, Lv W, Xie X, et al. The value of hysteroscopy and transvaginal ultrasonography in the diagnosis of endometrial hyperplasia: a systematic review and meta-analysis. Transl Cancer Res. 2019;8(4):1179–1187. doi: 10.21037/tcr.2019.06.33.
   PubMed Web of Science ®Google Scholar
• Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 2002;288(13):1610–1621. doi: 10.1001/jama.288.13.1610.
   PubMed Web of Science ®Google Scholar
• Xu J, Qiao L, Xiong K, et al. Diagnostic value of quantitative analysis by contrast-enhanced ultrasound of endometrial lesions. J Ultrasound Med. 2021;40(6):1131–1136. doi: 10.1002/jum.15492.
   PubMed Web of Science ®Google Scholar
• Su Q, Sun Z, Lv G. Contrast enhanced ultrasound in diagnosis of endometrial carcinoma and endometrial hyperplasia. Cell Mol Biol (Noisy-le-Grand). 2018;64(11):88–91. doi: 10.14715/cmb/2018.64.11.16.
   PubMed Web of Science ®Google Scholar
• De Franciscis P, Riemma G, Schiattarella A, et al. Concordance between the hysteroscopic diagnosis of endometrial hyperplasia and histopathological examination. Diagnostics (Basel). 2019;9(4):142. doi: 10.3390/diagnostics9040142.
   PubMedGoogle Scholar
• Ianieri MM, Staniscia T, Pontrelli G, et al. A new hysteroscopic risk scoring system for diagnosing endometrial hyperplasia and adenocarcinoma. J Minim Invasive Gynecol. 2016;23(5):712–718. doi: 10.1016/j.jmig.2016.02.017.
   PubMed Web of Science ®Google Scholar
• Gan DE, Jawan RA, Moy FM. Concordance between hysteroscopic impression and endometrial histopathological diagnosis. Prev Med. 2013;57 Suppl(Suppl):S21–S3. doi: 10.1016/j.ypmed.2012.12.026.
   PubMedGoogle Scholar
• Lasmar RB, Dias R, Barrozo PR, et al. Prevalence of hysteroscopic findings and histologic diagnoses in patients with abnormal uterine bleeding. Fertil Steril. 2008;89(6):1803–1807. doi: 10.1016/j.fertnstert.2007.05.045.
   PubMed Web of Science ®Google Scholar
• Török P, Molnár S, Lampé R, et al. The use of hysteroscopy in endometrial cancer: old questions and novel challenges. Climacteric. 2020;23(4):330–335. doi: 10.1080/13697137.2020.1732914.
   PubMed Web of Science ®Google Scholar
• Bourdel N, Chauvet P, Tognazza E, et al. Sampling in atypical endometrial hyperplasia: which method results in the lowest underestimation of endometrial cancer? A systematic review and meta-analysis. J Minim Invasive Gynecol. 2016;23(5):692–701. doi: 10.1016/j.jmig.2016.03.017.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Riemma G, Haimovich S, et al. Risk of endometrial cancer in asymptomatic postmenopausal women in relation to ultrasonographic endometrial thickness: systematic review and diagnostic test accuracy meta-analysis. Am J Obstet Gynecol. 2023 Jan;228(1):22–35.e2. doi: 10.1016/j.ajog.2022.07.043.
   Web of Science ®Google Scholar
• Travaglino A, Raffone A, Saccone G, et al. Significant risk of occult cancer in complex non-atypical endometrial hyperplasia. Arch Gynecol Obstet. 2019;300(5):1147–1154. doi: 10.1007/s00404-019-05299-2.
   PubMed Web of Science ®Google Scholar
• Chandra V, Kim JJ, Benbrook DM, et al. Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol. 2016;27(1):e8. doi: 10.3802/jgo.2016.27.e8.
   PubMed Web of Science ®Google Scholar
• Wildemeersch D, Dhont M. Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system. Am J Obstet Gynecol. 2003;188(5):1297–1298. doi: 10.1067/mob.2003.346.
   PubMed Web of Science ®Google Scholar
• Casper RF. Regulation of estrogen/progestogen receptors in the endometrium. Int J Fertil Menopausal Stud. 1996;41(1):16–21.
   PubMedGoogle Scholar
• Daniel AR, Knutson TP, Lange CA. Signaling inputs to progesterone receptor gene regulation and promoter selectivity. Mol Cell Endocrinol. 2009;308(1–2):47–52. doi: 10.1016/j.mce.2009.01.004.
   PubMed Web of Science ®Google Scholar
• Wildemeersch D, Janssens D, Pylyser K, et al. Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up. Maturitas. 2007;57(2):210–213. doi: 10.1016/j.maturitas.2006.12.004.
   PubMed Web of Science ®Google Scholar
• Reed SD, Voigt LF, Newton KM, et al. Progestin therapy of complex endometrial hyperplasia with and without atypia. Obstet Gynecol. 2009;113(3):655–662. doi: 10.1097/AOG.0b013e318198a10a.
   PubMed Web of Science ®Google Scholar
• Ismail MT, Fahmy DM, Elshmaa NS. Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia. Reprod Sci. 2013;20(1):45–50. doi: 10.1177/1933719112459243.
   PubMed Web of Science ®Google Scholar
• Dolapcioglu K, Boz A, Baloglu A. The efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia. A prospective randomized comparative study. Clin Exp Obstet Gynecol. 2013;40(1):122–126.
   PubMed Web of Science ®Google Scholar
• Abu Hashim H, Zayed A, Ghayaty E, et al. LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial. J Gynecol Oncol. 2013;24(2):128–134. doi: 10.3802/jgo.2013.24.2.128.
   PubMed Web of Science ®Google Scholar
• Abu Hashim H, Ghayaty E, El Rakhawy M. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials. Am J Obstet Gynecol. 2015;213(4):469–478. doi: 10.1016/j.ajog.2015.03.037.
   PubMed Web of Science ®Google Scholar
• Behrouzi R, Ryan NAJ, Barr CE, et al. Baseline serum HE4 but not tissue HE4 expression predicts response to the levonorgestrel-releasing intrauterine system in atypical hyperplasia and early stage endometrial cancer. Cancers (Basel). 2020;12(2):276. doi: 10.3390/cancers12020276.
   PubMed Web of Science ®Google Scholar
• Mais V, Fais ML, Peiretti M, et al. HE4 tissue expression as a putative prognostic marker in low-risk/low-grade endometrioid endometrial cancer: a review. Curr Oncol. 2022;29(11):8540–8555. doi: 10.3390/curroncol29110673.
   PubMed Web of Science ®Google Scholar
• Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol. 2000;13(3):295–308. doi: 10.1038/modpathol.3880051.
   PubMed Web of Science ®Google Scholar
• Agorastos T, Vaitsi V, Pantazis K, et al. Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2005;118(2):239–240. doi: 10.1016/j.ejogrb.2004.07.002.
   PubMed Web of Science ®Google Scholar
• Tas M, Kutuk MS, Serin IS, et al. Comparison of antiproliferative effects of metformine and progesterone on estrogen-induced endometrial hyperplasia in rats. Gynecol Endocrinol. 2013;29(4):311–314. doi: 10.3109/09513590.2012.743010.
   PubMed Web of Science ®Google Scholar
• Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20(2):235–244. doi: 10.1016/j.beem.2006.03.005.
   PubMed Web of Science ®Google Scholar
• Tan BK, Adya R, Chen J, et al. Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells. J Clin Endocrinol Metab. 2011;96(3):808–816. doi: 10.1210/jc.2010-1803.
   PubMed Web of Science ®Google Scholar
• Yilmaz B, Sucak A, Kilic S, et al. Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9. Am J Obstet Gynecol. 2010;202(4):368.e1-8–368.e8. doi: 10.1016/j.ajog.2009.10.873.
   PubMed Web of Science ®Google Scholar
• Guo M, Zhou JJ, Huang W. Metformin alleviates endometrial hyperplasia through the UCA1/miR‑144/TGF‑β1/AKT signaling pathway. Int J Mol Med. 2020;45(2):623–633. doi: 10.3892/ijmm.2019.4438.
   PubMed Web of Science ®Google Scholar
• Seufert J, Lübben G, Dietrich K, et al. A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus. Clin Ther. 2004;26(6):805–818. doi: 10.1016/s0149-2918(04)90125-7.
   PubMed Web of Science ®Google Scholar
• Bellin C, de Wiza DH, Wiernsperger NF, et al. Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin. Horm Metab Res. 2006;38(11):732–739. doi: 10.1055/s-2006-955084.
   PubMed Web of Science ®Google Scholar
• Meireles CG, Pereira SA, Valadares LP, et al. Effects of metformin on endometrial cancer: systematic review and meta-analysis. Gynecol Oncol. 2017;147(1):167–180. doi: 10.1016/j.ygyno.2017.07.120.
   PubMed Web of Science ®Google Scholar
• Sharifzadeh F, Aminimoghaddam S, Kashanian M, et al. A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia. Gynecol Endocrinol. 2017;33(2):152–155. doi: 10.1080/09513590.2016.1223285.
   PubMed Web of Science ®Google Scholar
• Tehranian A, Ghahghaei-Nezamabadi A, Arab M, et al. The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial. J Gynecol Obstet Hum Reprod. 2021;50(6):101863. doi: 10.1016/j.jogoh.2020.101863.
   PubMed Web of Science ®Google Scholar
• Liu M, Zhu H, Zhu Y, et al. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway. J Ethnopharmacol. 2021;270:113821. doi: 10.1016/j.jep.2021.113821.
   PubMed Web of Science ®Google Scholar
• Lu CC, Shen CH, Chang CB, et al. Guizhi Fuling Wan as a novel agent for intravesical treatment for bladder cancer in a mouse model. Mol Med. 2016;22:64–73. doi: 10.2119/molmed.2015.00085.
   PubMed Web of Science ®Google Scholar
• Sun L, Liu L, Zong S, et al. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction. J Ethnopharmacol. 2016;191:273–279. doi: 10.1016/j.jep.2016.06.042.
   PubMed Web of Science ®Google Scholar
• Wang C, Chen J, Xiao Y, et al. Guizhi Fuling wan for chronic pelvic inflammatory disease protocol: a protocol for systematic review and meta analysis. Medicine (Baltimore). 2020;99(51):e23549. doi: 10.1097/MD.0000000000023549.
   PubMedGoogle Scholar
• Zhu Y, Li Y, Liu M, et al. Guizhi Fuling Wan, Chinese herbal medicine, ameliorates insulin sensitivity in PCOS model rats with insulin resistance via remodeling intestinal homeostasis. Front Endocrinol (Lausanne). 2020;11:575. doi: 10.3389/fendo.2020.00575.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhang T, Song C, et al. Guizhi Fuling Capsule ameliorates endometrial hyperplasia through promoting p62-Keap1-NRF2-mediated ferroptosis. J Ethnopharmacol. 2021;274:114064. doi: 10.1016/j.jep.2021.114064.
   PubMed Web of Science ®Google Scholar
• Jung YW, Lee BM, Ha MT, et al. Lignans from Saururus chinensis exhibit anti-inflammatory activity by influencing the Nrf2/HO-1 activation pathway. Arch Pharm Res. 2019;42(4):332–343. doi: 10.1007/s12272-018-1093-4.
   PubMed Web of Science ®Google Scholar
• Park YJ, Moon C, Kang JH, et al. Antiviral effects of extracts from Celosia cristata and Raphanus sativus roots against viral hemorrhagic septicemia virus. Arch Virol. 2017;162(6):1711–1716. doi: 10.1007/s00705-017-3270-z.
   PubMed Web of Science ®Google Scholar
• Inami K, Asada Y, Harada T, et al. Antimutagenic components in Spatholobus suberectus Dunn against N-methyl-N-nitrosourea. Genes Environ. 2019;41:22. doi: 10.1186/s41021-019-0137-4.
   PubMed Web of Science ®Google Scholar
• Lv B, Peng YD, Fu WH, et al. A traditional Chinese medicine for the treatment of endometrial hyperplasia via regulating the HPO axis in rats. Evid Based Complement Alternat Med. 2022;2022:5200608.
   PubMed Web of Science ®Google Scholar
• Vilos GA, Oraif A, Vilos AG, et al. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding. J Minim Invasive Gynecol. 2015;22(1):66–77. doi: 10.1016/j.jmig.2014.07.009.
   PubMed Web of Science ®Google Scholar
• Takac I, Zegura B. Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer. Gynecol Oncol. 2007;107(1):94–98. doi: 10.1016/j.ygyno.2007.05.031.
   PubMed Web of Science ®Google Scholar
• Cianferoni L, Giannini A, Franchini M. Hysteroscopic resection of endometrial hyperplasia. J Am Assoc Gynecol Laparosc. 1999;6(2):151–154. doi: 10.1016/s1074-3804(99)80093-0.
   PubMedGoogle Scholar
• Vilos GA, Alzawawi N, Oraif A, et al. Hysteroscopic endometrial resection in women treated with tamoxifen for breast cancer provides definitive diagnosis and effective long-term therapy. J Obstet Gynaecol Can. 2022;44(5):517–520. doi: 10.1016/j.jogc.2021.12.007.
   PubMed Web of Science ®Google Scholar
• Mueller JJ, Rios-Doria E, Park KJ, et al. Sentinel lymph node mapping in patients with endometrial hyperplasia: a practice to preserve or abandon?. Gynecol Oncol. 2023;168:1–7. doi: 10.1016/j.ygyno.2022.10.017.
   PubMed Web of Science ®Google Scholar
• Capozzi VA, Sozzi G, Butera D, et al. Nodal assessment in endometrial atypical hyperplasia. Gynecol Obstet Invest. 2022;87(3–4):226–231. doi: 10.1159/000525850.
   PubMed Web of Science ®Google Scholar
• Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106(4):812–819. doi: 10.1002/cncr.21650.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Ramzan AA, Gualtieri MR, et al. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia. Gynecol Oncol. 2015;139(2):261–267. doi: 10.1016/j.ygyno.2015.07.108.
   PubMed Web of Science ®Google Scholar
• Lin CY, Wu RC, Yang LY, et al. MicroRNAs as predictors of future uterine malignancy in endometrial hyperplasia without atypia. J Pers Med. 2022;12(2):311.
   PubMed Web of Science ®Google Scholar